• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
[The role of citicoline in glaucoma].[胞磷胆碱在青光眼治疗中的作用]
Ophthalmologe. 2021 May;118(5):439-448. doi: 10.1007/s00347-021-01362-z. Epub 2021 Mar 17.
2
Citicoline - a neuroprotector with proven effects on glaucomatous disease.胞磷胆碱——一种对青光眼疾病有确切疗效的神经保护剂。
Rom J Ophthalmol. 2017 Jul-Sep;61(3):152-158. doi: 10.22336/rjo.2017.29.
3
Cytidine 5'-Diphosphocholine (Citicoline): Evidence for a Neuroprotective Role in Glaucoma.胞苷二磷酸胆碱(胞磷胆碱):在青光眼的神经保护作用中的证据。
Nutrients. 2020 Mar 18;12(3):793. doi: 10.3390/nu12030793.
4
Cytidine 5'-Diphosphocholine (Citicoline) in Glaucoma: Rationale of Its Use, Current Evidence and Future Perspectives.胞苷5'-二磷酸胆碱(胞磷胆碱)在青光眼治疗中的应用:使用原理、现有证据及未来展望
Int J Mol Sci. 2015 Nov 30;16(12):28401-17. doi: 10.3390/ijms161226099.
5
[The effect of parenteral citicoline on visual functions and life quality of patients with primary open-angle glaucoma].[胃肠外注射胞磷胆碱对原发性开角型青光眼患者视觉功能和生活质量的影响]
Vestn Oftalmol. 2011 Sep-Oct;127(5):18-21.
6
Evidence of the neuroprotective role of citicoline in glaucoma patients.胞磷胆碱在青光眼患者中的神经保护作用证据。
Prog Brain Res. 2008;173:541-54. doi: 10.1016/S0079-6123(08)01137-0.
7
Treatment with citicoline eye drops enhances retinal function and neural conduction along the visual pathways in open angle glaucoma.使用胞磷胆碱滴眼液进行治疗可增强开角型青光眼患者视网膜功能以及沿视觉通路的神经传导。
Graefes Arch Clin Exp Ophthalmol. 2015 Aug;253(8):1327-40. doi: 10.1007/s00417-015-3044-9. Epub 2015 May 26.
8
Pharmacodynamics of citicoline relevant to the treatment of glaucoma.胞磷胆碱与青光眼治疗相关的药效学。
J Neurosci Res. 2002 Jan 15;67(2):143-8. doi: 10.1002/jnr.10129.
9
The effect of citicoline oral solution on quality of life in patients with glaucoma: the results of an international, multicenter, randomized, placebo-controlled cross-over trial.胞磷胆碱口服溶液对青光眼患者生活质量的影响:一项国际、多中心、随机、安慰剂对照交叉试验的结果
Graefes Arch Clin Exp Ophthalmol. 2023 Jun;261(6):1659-1668. doi: 10.1007/s00417-022-05947-5. Epub 2023 Jan 14.
10
Citicoline and Retinal Ganglion Cells: Effects on Morphology and Function.胞磷胆碱与视网膜神经节细胞:对形态和功能的影响。
Curr Neuropharmacol. 2018;16(7):919-932. doi: 10.2174/1570159X15666170703111729.

引用本文的文献

1
Efficacy of citicoline as a supplement in glaucoma patients: A systematic review.胞磷胆碱作为青光眼患者补充剂的疗效:系统评价。
PLoS One. 2023 Sep 28;18(9):e0291836. doi: 10.1371/journal.pone.0291836. eCollection 2023.
2
Citicoline: pharmacological and clinical review, 2022 update.胞磷胆碱:药理学和临床综述,2022 年更新。
Rev Neurol. 2022 Nov 30;75(s05):S1-S89. doi: 10.33588/rn.75s05.2022311.

本文引用的文献

1
Topical citicoline and vitamin B12 versus placebo in the treatment of diabetes-related corneal nerve damage: a randomized double-blind controlled trial.局部胞磷胆碱和维生素 B12 治疗糖尿病相关角膜神经损伤与安慰剂的随机双盲对照试验。
BMC Ophthalmol. 2020 Aug 1;20(1):315. doi: 10.1186/s12886-020-01584-w.
2
Can Treatment With Citicoline Eyedrops Reduce Progression in Glaucoma? The Results of a Randomized Placebo-controlled Clinical Trial.胞磷胆碱滴眼液治疗能否减缓青光眼进展?一项随机安慰剂对照临床试验的结果。
J Glaucoma. 2020 Jul;29(7):513-520. doi: 10.1097/IJG.0000000000001565.
3
Neurodegeneration in Alzheimer's disease and glaucoma: overlaps and missing links.阿尔茨海默病和青光眼的神经退行性变:重叠和缺失的环节。
Eye (Lond). 2020 Sep;34(9):1546-1553. doi: 10.1038/s41433-020-0836-x. Epub 2020 Mar 9.
4
Human vitreous concentrations of citicoline following topical application of citicoline 2% ophthalmic solution.人眼玻璃体内的胞磷胆碱浓度在局部使用 2%胞磷胆碱滴眼溶液后的变化。
PLoS One. 2019 Nov 14;14(11):e0224982. doi: 10.1371/journal.pone.0224982. eCollection 2019.
5
Morphological and Functional Evaluation of Oral Citicoline Therapy in Chronic Open-Angle Glaucoma Patients: A Pilot Study With a 2-Year Follow-Up.慢性开角型青光眼患者口服胞磷胆碱治疗的形态学和功能评估:一项为期2年随访的初步研究
Front Pharmacol. 2019 Sep 26;10:1117. doi: 10.3389/fphar.2019.01117. eCollection 2019.
6
Cholinergic nervous system and glaucoma: From basic science to clinical applications.胆碱能神经系统与青光眼:从基础科学到临床应用。
Prog Retin Eye Res. 2019 Sep;72:100767. doi: 10.1016/j.preteyeres.2019.06.003. Epub 2019 Jun 23.
7
Oral Memantine for the Treatment of Glaucoma: Design and Results of 2 Randomized, Placebo-Controlled, Phase 3 Studies.口服美金刚治疗青光眼:两项随机、安慰剂对照、3 期研究的设计和结果。
Ophthalmology. 2018 Dec;125(12):1874-1885. doi: 10.1016/j.ophtha.2018.06.017. Epub 2018 Aug 3.
8
Cytidine-5'-Diphosphocholine Protects the Liver From Ischemia/Reperfusion Injury Preserving Mitochondrial Function and Reducing Oxidative Stress.胞苷-5'-二磷酸胆碱通过保护线粒体功能和减少氧化应激减轻肝缺血/再灌注损伤。
Liver Transpl. 2018 Aug;24(8):1070-1083. doi: 10.1002/lt.25179.
9
Agonistic Autoantibodies to the β2-Adrenergic Receptor Involved in the Pathogenesis of Open-Angle Glaucoma.β2-肾上腺素能受体激动性自身抗体与开角型青光眼发病机制有关。
Front Immunol. 2018 Feb 12;9:145. doi: 10.3389/fimmu.2018.00145. eCollection 2018.
10
Glaucoma and intraocular pressure in EPIC-Norfolk Eye Study: cross sectional study.英国诺福克地区眼病前瞻性研究(EPIC-Norfolk)中的青光眼与眼压:横断面研究
BMJ. 2017 Sep 13;358:j3889. doi: 10.1136/bmj.j3889.

[胞磷胆碱在青光眼治疗中的作用]

[The role of citicoline in glaucoma].

作者信息

Jünemann Anselm G M, Grieb P, Rejdak R

机构信息

Department of General and Pediatric Ophthalmology Service, Medical University of Lublin, Chmielna 1 str., 20-079, Lublin, Polen.

Department of Experimental Pharmacology, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warschau, Polen.

出版信息

Ophthalmologe. 2021 May;118(5):439-448. doi: 10.1007/s00347-021-01362-z. Epub 2021 Mar 17.

DOI:10.1007/s00347-021-01362-z
PMID:33730306
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7967777/
Abstract

BACKGROUND

In recent years, many experimental and clinical studies have shown that in glaucoma, neuronal degeneration occurs not only at the level of the retina and optic nerve, but also along the entire visual pathway and the brain.

OBJECTIVE

This article presents the neuroprotective effects of citicoline and their mechanisms in glaucoma disease.

MATERIALS AND METHODS

The relevance of citicoline is explained against the background of neuroanatomy, neuroimaging, and the pathogenesis of glaucoma. Data from experimental and clinical studies are presented and a conclusion is drawn for clinical application.

RESULTS

Citicoline has a neuroprotective effect via mechanisms relevant to glaucoma. The neuroprotective effect of citicoline in open-angle glaucoma can be demonstrated functionally and morphologically. It is independent of the glaucoma damage and intraocular pressure, and usually occurs only after 1 year. The effects of oral citicoline occur at a daily dose of 500-1000 mg. Citicoline can be taken permanently or in cycles. No side effects occurred in the studies when taking citicoline. Citicoline can improve cognitive performance and thus treatment adherence as well as quality of life in glaucoma patients.

CONCLUSION

This relatively old nootropic drug, which is now marketed as a food supplement, seems to be a valuable addition to conventional treatment and also a rational option for prophylaxis of open-angle glaucoma.

摘要

背景

近年来,许多实验和临床研究表明,在青光眼患者中,神经元变性不仅发生在视网膜和视神经水平,还发生在整个视觉通路及大脑。

目的

本文介绍了胞磷胆碱在青光眼疾病中的神经保护作用及其机制。

材料与方法

在神经解剖学、神经影像学及青光眼发病机制的背景下解释胞磷胆碱的相关性。展示了实验和临床研究的数据,并得出临床应用结论。

结果

胞磷胆碱通过与青光眼相关的机制发挥神经保护作用。胞磷胆碱在开角型青光眼中的神经保护作用可通过功能和形态学得到证实。它独立于青光眼损害和眼压,通常仅在1年后出现。口服胞磷胆碱的效果在每日剂量500 - 1000毫克时出现。胞磷胆碱可以长期服用或循环服用。在服用胞磷胆碱的研究中未出现副作用。胞磷胆碱可以改善认知能力,从而提高青光眼患者的治疗依从性及生活质量。

结论

这种相对古老的促智药,现作为食品补充剂销售,似乎是传统治疗的宝贵补充,也是预防开角型青光眼的合理选择。